REMAP-ATTACC
Antithrombotic Therapy to Ameliorate Complications of COVID-19
Registration:
Sponsors:
University of Manitoba
Collaborator: University Health Network, Toronto
Status:
No longer recruiting
Design
A prospective, open-label, randomized, multicentre, adaptive clinical trial
Participating Sites
Lead Network:
CanVECTOR
Countries:
Canada,Lead Investigators
Ryan Zarychanski, MD, MSc
rzarychanski@cancercare.mb.caSubscribe